Sub Banner Image

Drugmakers Mallinckrodt and Endo Are in Talks to Merge

Markets

Michelle F Davis, Dinesh Nair

·

March 12, 2025

·

Bloomberg

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people with knowledge of the matter said.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.